← All businessesHealthcare & Life Sciences / Pharmacies / Online pharmacy
Large Online Pharmacy With Nationwide Reach, Based In Bristol
Bristol, Bristol, South WestIdentity protected
Available

About this business
A large online pharmacy run from Bristol, trading since 2014 and supplying prescription treatments, everyday medicines and wellbeing lines to patients all over the UK. Turnover has grown every year, from £11.19m in 2021 to £13.3m, while EBITDA has fallen from £3.08m to £2.68m as the business spent more to win new customers. Margins remain healthy at about 20%. Forty people work across pharmacy, dispatch, technology and customer service. There are no premises in the sale. The asking price is £21m, and a buyer would be taking on a sizeable, profitable operation with room to work on costs.
Key investment highlights
- Turnover of £13.3m, up every year
- EBITDA of £2.68m
- Team of 40 across pharmacy and tech
- Selling to customers across the UK
Reason for sale
The investors who backed the founders have reached the end of their planned holding period.
Nothing flagged on the two questions buyers ask first
No flagRevenue going backwards and one client being too much of it are the two things that end most deals in due diligence. Both are shown here up front, from the figures the seller supplied.
- Revenue directionNo flag
Turnover rose +3.4% in 2026.
- 2021: baseline
- 2022 (+1.5%)
- 2023 (+4.1%)
- 2024 (+5.9%)
- 2025 (+2.7%)
- 2026 (+3.4%)
6 years of turnover, 2021 to 2026, as supplied by the seller.
- Client concentrationNot stated
The seller has not declared what share of revenue the largest clients represent.
No declaration supplied. Client concentration cannot be derived from accounts.
EBITDA margin narrowed from 27.5% in 2021 to 20.1% in 2026.
These are observations from the supplied figures, not a view on whether this business is worth buying. Nothing here predicts an outcome.
Computing valuation...
What happens next
Submit an enquiry to the seller. Once they approve it, you sign a non-disclosure agreement and gain access to the information memorandum, the financials and a secure deal room with the seller.

